<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7998962" created="30/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7998962</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Constitutive <term id="T1" lex="nuclear_NF-kappa_B" sem="Protein_molecule">nuclear <term id="A21" sem="Protein_complex">NF-kappa B</term></term> in cells of the monocyte lineage.</sentence>
<event KT="Investigation" id="E61">
<type class="Gene_expression"/>
<theme idref="A21"/>
<clue><clueType>Constitutive</clueType> <clueLoc>nuclear</clueLoc> NF-kappa B <clueLoc>in cells of the monocyte lineage</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In <term id="T2" lex="monocyte" sem="Cell_natural">monocytes</term>, the <term id="T3" lex="nuclear_factor_NF-kappa_B" sem="Protein_molecule">nuclear factor <term id="T4" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> has been invoked as an important <term id="T5" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> in the expression of <term id="T6" lex="cytokine_gene" sem="DNA_family_or_group">cytokine genes</term>, of <term id="T7" lex="cell-surface_receptor" sem="Protein_family_or_group">cell-surface receptors</term> and in the expression of <term id="T8" lex="human_immunodeficiency_virus" sem="DNA_domain_or_region">human immunodeficiency virus</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>In monocytes, the nuclear factor NF-kappa B has been invoked as an important transcription factor in the <clueType>expression</clueType> <linkTheme>of</linkTheme> cytokine genes, of cell-surface receptors and in the expression of human immunodeficiency virus.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue>In monocytes, the nuclear factor NF-kappa B has been invoked as an important transcription factor in the <clueType>expression</clueType> of cytokine genes, <linkTheme>of</linkTheme> cell-surface receptors and in the expression of human immunodeficiency virus.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T8"/>
<clue>In monocytes, the nuclear factor NF-kappa B has been invoked as an important transcription factor in the expression of cytokine genes, of cell-surface receptors and in the <clueType>expression</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus.</clue>
<comment>NER: T8 MOD</comment></event>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue><clueLoc>In monocytes</clueLoc>, the nuclear factor NF-kappa B has been invoked as an <clueType>important</clueType> transcription factor <linkTheme>in</linkTheme> the expression of cytokine genes, of cell-surface receptors and in the expression of human immunodeficiency virus.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="E2"/>
<cause idref="T4"/>
<clue><clueLoc>In monocytes</clueLoc>, the nuclear factor NF-kappa B has been invoked as an <clueType>important</clueType> transcription factor <linkTheme>in</linkTheme> the expression of cytokine genes, of cell-surface receptors and in the expression of human immunodeficiency virus.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="T4"/>
<clue><clueLoc>In monocytes</clueLoc>, the nuclear factor NF-kappa B has been invoked as an <clueType>important</clueType> transcription factor in the expression of cytokine genes, of cell-surface receptors and <linkTheme>in</linkTheme> the expression of human immunodeficiency virus.</clue>
</event>
<sentence id="S3">In such cells, <term id="T9" lex="DNA_binding_activity" sem="Other"><term id="A1" sem="DNA_molecule">DNA</term> binding activity</term> of <term id="T10" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> can be detected without <term id="A2" sem="Other">intentional stimulation</term>.</sentence>
<event KT="Other" id="E7">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="A1"/>
<clue>In such cells, DNA <clueType>binding activity</clueType> <linkTheme>of</linkTheme> NF-kappa B can be detected without intentional stimulation.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E8">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="A2"/>
<clue>In such cells, DNA binding activity of NF-kappa B can be <clueType>detected <cluePolarity>without</cluePolarity></clueType> intentional stimulation.</clue>
</event>
<sentence id="S4">In our studies, cells of the <term id="T11" lex="human_monocytic_line" sem="Cell_cultured">human monocytic line</term> <term id="T12" lex="Mono_Mac_6" sem="Cell_cultured">Mono Mac 6</term>, cultured in medium containing <term id="T13" lex="fetal-calf_serum" sem="Tissue_natural">fetal-calf serum</term> and low levels of <term id="T14" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T15" lex="LPS" sem="Lipid">LPS</term>), also exhibit such &apos;constitutive&apos; <term id="T16" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>, as demonstrated by mobility-shift analysis of <term id="T17" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term>.</sentence>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T16"/>
<clue>In our studies, cells of the human monocytic line Mono Mac 6, cultured in medium containing fetal-calf serum and low levels of lipopolysaccharide (LPS), also exhibit such &apos;<clueType>constitutive</clueType>&apos; NF-kappa B, as demonstrated by mobility-shift analysis of nuclear extracts.</clue>
</event>
<event KT="Other" id="E62">
<type class="Physiological_process"/>
<theme idref="T12"/>
<cause idref="T13"/>
<cause idref="T15"/>
<clue>In our studies, cells of the human monocytic line Mono Mac 6, <clueType>cultured in medium</clueType> <linkCause>containing</linkCause> fetal-calf serum and low levels of lipopolysaccharide (LPS), also exhibit such &apos;constitutive&apos; NF-kappa B, as demonstrated by mobility-shift analysis of nuclear extracts.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E62"/>
<clue>In our studies, cells of the human monocytic line Mono Mac 6, cultured in medium containing fetal-calf serum and low levels of lipopolysaccharide (LPS), also <clueType><clueKT>exhibit</clueKT></clueType> such &apos;constitutive&apos; NF-kappa B, as demonstrated <clueExperiment>by mobility-shift analysis of nuclear extracts</clueExperiment>.</clue>
</event>
<sentence id="S5">This <term id="T18" lex="nuclear_NF-kappa_B" sem="Protein_molecule">nuclear <term id="T19" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> was still present when contaminant <term id="T20" lex="LPS" sem="Lipid">LPS</term> was removed by <term id="T21" lex="ultrafiltration" sem="Other">ultrafiltration</term> and when <term id="T22" lex="serum" sem="Tissue_natural">serum</term> was omitted.</sentence>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<clue><corefTheme>This nuclear NF-kappa B</corefTheme> was still <clueType>present</clueType> <clueExperiment>when contaminant LPS was removed by ultrafiltration and when serum was omitted.</clueExperiment></clue>
</event>
<event id="E63">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<clue>This nuclear NF-kappa B was still present when contaminant LPS was <clueType>removed</clueType> <clueExperiment>by ultrafiltration</clueExperiment> and when serum was omitted.</clue>
</event>
<event Polarity="Negative" id="E64">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<clue>This nuclear NF-kappa B was still present when contaminant LPS was removed by ultrafiltration and when serum was <clueType><cluePolarity>omitted</cluePolarity></clueType>.</clue>
</event>
<sentence id="S6">Protein-DNA complexes of <term id="A3" sem="Protein_complex">constitutive <term id="T23" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> are similar in mobility to the <term id="T24" lex="LPS-induced_NF-kappa_B" sem="Protein_molecule"><term id="T25" lex="LPS" sem="Lipid">LPS</term>-induced <term id="T26" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> and both are recognized by an <term id="A4" sem="Protein_family_or_group">antibody specific to the <term id="T27" lex="p50_subunit" sem="Protein_molecule">p50 subunit</term></term> of <term id="T28" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</sentence>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="T25"/>
<clue>Protein-DNA complexes of constitutive NF-kappa B are similar in mobility to the LPS-<clueType>induced</clueType> NF-kappa B and both are recognized by an antibody specific to the p50 subunit of NF-kappa B.</clue>
</event>
<event KT="Analysis" id="E13">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="A4"/>
<clue>Protein-DNA complexes of constitutive NF-kappa B are similar in mobility to the LPS-induced NF-kappa B and both are <clueType><clueKT>recognized</clueKT></clueType> <linkTheme>by</linkTheme> an antibody specific to the p50 subunit of NF-kappa B.</clue>
<comment>TPS: A4</comment></event>
<event KT="Analysis" id="E14">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="A4"/>
<clue>Protein-DNA complexes of constitutive NF-kappa B are similar in mobility to the LPS-induced NF-kappa B and both are <clueType><clueKT>recognized</clueKT></clueType> <linkTheme>by</linkTheme> an antibody specific to the p50 subunit of NF-kappa B.</clue>
</event>
<event id="E50">
<type class="Gene_expression"/>
<theme idref="T23"/>
<clue>Protein-DNA complexes of <clueType>constitutive</clueType> NF-kappa B are similar in mobility to the LPS-induced NF-kappa B and both are recognized by an antibody specific to the p50 subunit of NF-kappa B.</clue>
</event>
<sentence id="S7">By contrast, treatment of cells with <term id="T29" lex="pyrrolidine_dithiocarbamate" sem="Organic_compound_other">pyrrolidine dithiocarbamate</term> (<term id="T30" lex="PDTC" sem="Organic_compound_other">PDTC</term>) will only block <term id="T31" lex="LPS-induced_NF-kappa_B" sem="Protein_molecule"><term id="T32" lex="LPS" sem="Lipid">LPS</term>-induced <term id="T33" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term>, but not the <term id="T34" lex="constitutive_binding_protein" sem="Protein_family_or_group">constitutive binding protein</term>.</sentence>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="T32"/>
<clue>By contrast, treatment of cells with pyrrolidine dithiocarbamate (PDTC) will only block LPS-<clueType>induced</clueType> NF-kappa B, but not the constitutive binding protein.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E16">
<type class="Negative_regulation"/>
<theme idref="A3"/>
<cause idref="T30"/>
<clue>By contrast, treatment of cells with pyrrolidine dithiocarbamate (PDTC) will only <clueType>block</clueType> LPS-induced NF-kappa B, but <cluePolarity>not</cluePolarity> <corefTheme>the constitutive binding protein</corefTheme>.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="T31"/>
<cause idref="T30"/>
<clue>By contrast, treatment of cells with pyrrolidine dithiocarbamate (PDTC) will only <clueType>block</clueType> LPS-induced NF-kappa B, but not the constitutive binding protein.</clue>
</event>
<sentence id="S8">Using <cons id="T35" lex="(AND LPS-free_condition serum-free_condition)" sem="(AND Other Other)"><frag id="F1">LPS-free</frag> and <frag id="F2">serum-free</frag> <frag id="F3">conditions</frag></cons>, constitutive <term id="T36" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> can be detected in different <term id="T37" lex="cell_line" sem="Cell_cultured">cell lines</term> of the <term id="T38" lex="monocytic_lineage" sem="Cell_natural">monocytic lineage</term> (<term id="T39" lex="HL60" sem="Cell_cultured">HL60</term>, <term id="T40" lex="U937" sem="Cell_cultured">U937</term>, <term id="T41" lex="THP-1" sem="Cell_cultured">THP-1</term>, <term id="T42" lex="Mono_Mac_1" sem="Cell_cultured">Mono Mac 1</term> and <term id="T43" lex="Mono_Mac_6" sem="Cell_cultured">Mono Mac 6</term>), but not in <term id="T44" lex="Molt_4_T_cell" sem="Cell_cultured">Molt 4 T cells</term> or <term id="T45" lex="K562_stem_cell" sem="Cell_cultured">K562 stem cells</term>.</sentence>
<event CL="L2" KT="Analysis" id="E300">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> <clueLoc>in</clueLoc> different <clueLoc>cell lines of the monocytic lineage</clueLoc> (<clueLoc>HL60</clueLoc>, U937, THP-1, Mono Mac 1 and Mono Mac 6), but not in Molt 4 T cells or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E301">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> <clueLoc>in</clueLoc> different <clueLoc>cell lines of the monocytic lineage</clueLoc> (HL60, <clueLoc>U937</clueLoc>, THP-1, Mono Mac 1 and Mono Mac 6), but not in Molt 4 T cells or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E302">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> <clueLoc>in</clueLoc> different <clueLoc>cell lines of the monocytic lineage</clueLoc> (HL60, U937, <clueLoc>THP-1</clueLoc>, Mono Mac 1 and Mono Mac 6), but not in Molt 4 T cells or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E303">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> <clueLoc>in</clueLoc> different <clueLoc>cell lines of the monocytic lineage</clueLoc> (HL60, U937, THP-1, <clueLoc>Mono Mac 1</clueLoc> and Mono Mac 6), but not in Molt 4 T cells or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E304">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> <clueLoc>in</clueLoc> different <clueLoc>cell lines of the monocytic lineage</clueLoc> (HL60, U937, THP-1, Mono Mac 1 and <clueLoc>Mono Mac 6</clueLoc>), but not in Molt 4 T cells or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E305">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> in different cell lines of the monocytic lineage (HL60, U937, THP-1, Mono Mac 1 and Mono Mac 6), but <cluePolarity>not</cluePolarity> <clueLoc>in Molt 4 T cells</clueLoc> or K562 stem cells.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E306">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>Using LPS-free and serum-free conditions</clueExperiment>, <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be <clueType>detected</clueType> in different cell lines of the monocytic lineage (HL60, U937, THP-1, Mono Mac 1 and Mono Mac 6), but <cluePolarity>not</cluePolarity> <clueLoc>in</clueLoc> Molt 4 T cells or <clueLoc>K562 stem cells</clueLoc>.</clue>
</event>
<sentence id="S9">When ordered according to stage of maturation, the amount of constitutive <term id="T46" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> was not increased in more <term id="T47" lex="mature_cell_line" sem="Cell_cultured">mature cell lines</term>.</sentence>
<event id="E21">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>When ordered according to stage of maturation, the amount of <clueType>constitutive</clueType> NF-kappa B was not increased in more mature cell lines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<clue>When ordered according to stage of maturation, the amount of constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>increased</clueType> <clueLoc>in more mature cell lines</clueLoc>.</clue>
</event>
<sentence id="S10">Furthermore, when inducing differentiation in <term id="T48" lex="Mono_Mac_6_cell" sem="Cell_cultured">Mono Mac 6 cells</term>, with <term id="T49" lex="vitamin_D3" sem="Lipid">vitamin D3</term>, no change in constitutive or inducible <term id="T50" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> can be detected.</sentence>
<event id="E23">
<type class="Cell_differentiation"/>
<theme idref="T48"/>
<clue>Furthermore, when inducing <clueType>differentiation</clueType> <linkTheme>in</linkTheme> Mono Mac 6 cells, with vitamin D3, no change in constitutive or inducible NF-kappa B can be detected.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T49"/>
<clue>Furthermore, when <clueType>inducing</clueType> differentiation in Mono Mac 6 cells, <linkCause>with</linkCause> vitamin D3, no change in constitutive or inducible NF-kappa B can be detected.</clue>
</event>
<event KT="Other" id="E25">
<type class="Gene_expression"/>
<theme idref="T50"/>
<clue>Furthermore, when inducing differentiation in Mono Mac 6 cells, with vitamin D3, no change in <clueType>constitutive</clueType> or inducible NF-kappa B can be detected.</clue>
</event>
<event KT="Other" id="E26">
<type class="Gene_expression"/>
<theme idref="T50"/>
<clue>Furthermore, when inducing differentiation in Mono Mac 6 cells, with vitamin D3, no change in constitutive or <clueType>inducible</clueType> NF-kappa B can be detected.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E27">
<type class="Regulation"/>
<theme idref="E25"/>
<cause idref="E24"/>
<clue>Furthermore, when inducing differentiation in Mono Mac 6 cells, with vitamin D3, <cluePolarity>no</cluePolarity> <clueType>change</clueType> <linkTheme>in</linkTheme> constitutive or inducible NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be detected.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E28">
<type class="Regulation"/>
<theme idref="E26"/>
<cause idref="E24"/>
<clue>Furthermore, when inducing differentiation in Mono Mac 6 cells, with vitamin D3, <cluePolarity>no</cluePolarity> <clueType>change</clueType> <linkTheme>in</linkTheme> constitutive or inducible NF-kappa B <clueKT><clueCL>can</clueCL></clueKT> be detected.</clue>
</event>
<sentence id="S11">Analysis of primary cells revealed substantial constitutive <term id="T51" lex="NF-kappa_B-binding_activity" sem="Other"><term id="T52" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>-binding activity</term> in <term id="T53" lex="blood_monocyte" sem="Cell_natural">blood <term id="T54" lex="monocyte" sem="Cell_natural">monocytes</term></term>, <term id="T55" lex="pleural_macrophage" sem="Cell_natural">pleural macrophages</term> and <term id="T56" lex="alveolar_macrophages" sem="Cell_natural">alveolar macrophages</term>.</sentence>
<event KT="Analysis" id="E320">
<type class="Binding"/>
<theme idref="T52"/>
<clue>Analysis of primary cells <clueKT>revealed</clueKT> substantial constitutive NF-kappa B-<clueType>binding activity</clueType> <clueLoc>in blood monocytes</clueLoc>, pleural macrophages and alveolar macrophages.</clue>
</event>
<event KT="Analysis" id="E321">
<type class="Binding"/>
<theme idref="T52"/>
<clue>Analysis of primary cells <clueKT>revealed</clueKT> substantial constitutive NF-kappa B-<clueType>binding activity</clueType> <clueLoc>in</clueLoc> blood monocytes, <clueLoc>pleural macrophages</clueLoc> and alveolar macrophages.</clue>
</event>
<event KT="Analysis" id="E322">
<type class="Binding"/>
<theme idref="T52"/>
<clue>Analysis of primary cells <clueKT>revealed</clueKT> substantial constitutive NF-kappa B-<clueType>binding activity</clueType> <clueLoc>in</clueLoc> blood monocytes, pleural macrophages and <clueLoc>alveolar macrophages</clueLoc>.</clue>
</event>
<sentence id="S12">The constitutive <term id="T57" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> appears to be functionally active, since a low level of <term id="T58" lex="tumour_necrosis_factor_(TNF)_transcript" sem="RNA_molecule">tumour necrosis factor (TNF) transcript</term> is detectable in <term id="T59" lex="monocyte" sem="Cell_natural">monocytes</term>, and this level can be increased by blocking <term id="A6" sem="Other">transcript degradation</term> using <term id="T60" lex="cycloheximide" sem="Organic_compound_other">cycloheximide</term>.</sentence>
<event CL="L2" KT="Analysis" id="E30">
<type class="Gene_expression"/>
<theme idref="T57"/>
<clue>The <clueType>constitutive</clueType> NF-kappa B <clueKT><clueCL>appears</clueCL></clueKT> to be functionally active, since a low level of tumour necrosis factor (TNF) transcript is detectable in monocytes, and this level can be increased by blocking transcript degradation using cycloheximide.</clue>
</event>
<event id="E31">
<type class="Transcription"/>
<theme idref="T58"/>
<clue>The constitutive NF-kappa B appears to be functionally active, since a low level of tumour necrosis factor (TNF) transcript is <clueType><clueKT>detectable</clueKT></clueType> <clueLoc>in monocytes</clueLoc>, and this level can be increased by blocking transcript degradation using cycloheximide.</clue>
</event>
<event KT="Other" id="E33">
<type class="Negative_regulation"/>
<theme idref="A6"/>
<cause idref="T60"/>
<clue>The constitutive NF-kappa B appears to be functionally active, since a low level of tumour necrosis factor (TNF) transcript is detectable in monocytes, and this level can be increased by <clueType>blocking</clueType> transcript degradation <linkCause>using</linkCause> cycloheximide.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="T58"/>
<cause idref="E33"/>
<clue>The constitutive NF-kappa B appears to be functionally active, since a low level of tumour necrosis factor (TNF) transcript is detectable in monocytes, and <corefTheme>this level</corefTheme> <clueKT><clueCL>can</clueCL></clueKT> be <clueType>increased</clueType> <linkCause>by</linkCause> blocking transcript degradation using cycloheximide.</clue>
</event>
<sentence id="S13">The level of constitutive <term id="T61" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in these cells is variable and is frequently found to be lower in the more <term id="T62" lex="mature_macrophage" sem="Cell_natural">mature macrophages</term>.</sentence>
<event KT="Other" id="E35">
<type class="Gene_expression"/>
<theme idref="T61"/>
<clue>The level of <clueType>constitutive</clueType> NF-kappa B in these cells is variable and is frequently found to be lower in the more mature macrophages.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<clue>The level of constitutive NF-kappa B in these cells is variable and is <clueKT>frequently</clueKT> found to be <clueType>lower</clueType> <clueLoc>in the more mature macrophages</clueLoc>.</clue>
</event>
<sentence id="S14">Constitutive <term id="T63" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> was not maintained by autocrine action of <term id="T64" lex="cytokine" sem="Protein_family_or_group">cytokines</term> <term id="T65" lex="TNF" sem="Protein_family_or_group">TNF</term>, <term id="T66" lex="interleukin_6" sem="Protein_molecule">interleukin 6</term>, <term id="A7" sem="Protein_molecule"><term id="T67" lex="interleukin" sem="Protein_molecule">interleukin</term> 10</term>, <term id="T68" lex="granulocyte-macrophage_colony-stimulating_factor" sem="Protein_molecule">granulocyte-macrophage colony-stimulating factor</term> or <term id="T69" lex="macrophage_colony-stimulating_factor" sem="Protein_molecule">macrophage colony-stimulating factor</term>, since <term id="A8" sem="Protein_family_or_group">neutralizing antibodies</term> did not reduce constitutive <term id="T70" lex="DNA-binding_activity" sem="Other"><term id="A9" sem="DNA_molecule">DNA</term>-binding activity</term>.</sentence>
<event KT="Other" id="E37">
<type class="Gene_expression"/>
<theme idref="T63"/>
<clue><clueType>Constitutive</clueType> NF-kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E38">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T64"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E39">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T65"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of <corefCause>cytokines</corefCause> TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T66"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of <corefCause>cytokines</corefCause> TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="A7"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of <corefCause>cytokines</corefCause> TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E42">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T68"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of <corefCause>cytokines</corefCause> TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T69"/>
<clue>Constitutive NF-kappa B was <cluePolarity>not</cluePolarity> <clueType>maintained</clueType> <linkCause>by</linkCause> autocrine action of <corefCause>cytokines</corefCause> TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity.</clue>
</event>
<event id="E44">
<type class="Binding"/>
<theme idref="T63"/>
<theme idref="A9"/>
<clue>Constitutive NF-kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-<clueType>binding activity</clueType>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E45">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="A8"/>
<clue>Constitutive NF-kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did <cluePolarity>not</cluePolarity> <clueType>reduce</clueType> constitutive DNA-binding activity.</clue>
</event>
<sentence id="S15">Furthermore, blockade of <term id="T71" lex="prostaglandin" sem="Lipid">prostaglandin</term> or <term id="T74" lex="leukotriene" sem="Organic_compound_other">leukotriene</term> biosynthesis did not affect constitutive <term id="T75" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</sentence>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T71"/>
<clue>Furthermore, blockade of prostaglandin or leukotriene <clueType>biosynthesis</clueType> did not affect constitutive NF-kappa B.</clue>
</event>
<event KT="Other" id="E47">
<type class="Positive_regulation"/>
<theme idref="T74"/>
<clue>Furthermore, blockade of prostaglandin or leukotriene <clueType>biosynthesis</clueType> did not affect constitutive NF-kappa B.</clue>
</event>
<event id="E48">
<type class="Negative_regulation"/>
<theme idref="E46"/>
<clue>Furthermore, <clueType>blockade</clueType> <linkTheme>of</linkTheme> prostaglandin or leukotriene biosynthesis did not affect constitutive NF-kappa B.</clue>
</event>
<event id="E49">
<type class="Negative_regulation"/>
<theme idref="E47"/>
<clue>Furthermore, <clueType>blockade</clueType> <linkTheme>of</linkTheme> prostaglandin or leukotriene biosynthesis did not affect constitutive NF-kappa B.</clue>
</event>
<event id="E51">
<type class="Gene_expression"/>
<theme idref="T75"/>
<clue>Furthermore, blockade of prostaglandin or leukotriene biosynthesis did not affect <clueType>constitutive</clueType> NF-kappa B.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E52">
<type class="Regulation"/>
<theme idref="E51"/>
<cause idref="E48"/>
<clue>Furthermore, blockade of prostaglandin or leukotriene biosynthesis did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> constitutive NF-kappa B.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E53">
<type class="Regulation"/>
<theme idref="E51"/>
<cause idref="E48"/>
<clue>Furthermore, blockade of prostaglandin or leukotriene biosynthesis did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> constitutive NF-kappa B.</clue>
</event>
<sentence id="S16">(ABSTRACT TRUNCATED AT 400 WORDS)</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
